3/5/26 17:01 | 3/3/26 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Underberg Sharon E. | ME | O | EVP,GC,C | M.d | 100 | 505.53 | 0 | 0 | 3 | 7 | D | | | | | | | | | | | | | | |
3/5/26 17:01 | 3/3/26 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Hunt Nimrata | ME | O | EVP | S | -1,116 | 634.57 | 0 | -2 | -9 | 18 | D | | | | | | | | | | | | | | |
3/2/26 17:00 | 2/26/26 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Mazelsky Jonathan Jay | ME | DO | P,CEO | M.dm | 3,403 | 144.65 | 0 | 24 | 39 | 84 | D | | | | | | | | | | | | | | |
3/2/26 17:00 | 2/26/26 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Mazelsky Jonathan Jay | ME | DO | P,CEO | S.d | -15,338 | 657.55 | 0 | -23 | -22 | 84 | D | | | | | | | | | | | | | | |
2/27/26 17:03 | 2/26/26 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Hunt Nimrata | ME | O | EVP | S | -1,782 | 661.54 | 0 | -3 | -12 | 20 | D | | | | | | | | | | | | | | |
2/19/26 18:00 | 2/17/26 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Erickson Michael G | ME | O | EVP | M.dm | 1,460 | 187.95 | 0 | 8 | 106 | 15 | D | | | | | | | | | | | | | | |
2/19/26 18:00 | 2/17/26 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Erickson Michael G | ME | O | EVP | S.d | -3,370 | 627.38 | 0 | -5 | -26 | 15 | D | | | | | | | | | | | | | | |
2/19/26 18:00 | 2/17/26 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Vandebroek Sophie V. | ME | D | | M.d | 316 | 333.90 | 0 | 1 | 12 | 9 | D | | | | | | | | | | | | | | |
2/19/26 18:00 | 2/17/26 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Vandebroek Sophie V. | ME | D | | S.d | -920 | 628.62 | 0 | -1 | -14 | 9 | D | | | | | | | | | | | | | | |
2/17/26 19:31 | 2/14/26 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Underberg Sharon E. | ME | O | EVP,GC,C | M.d | 0 | 0.00 | 0 | 1 | 14 | 7 | D | | | | | | | | | | | | | | |
2/17/26 19:31 | 2/14/26 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Smith Martin Alexander | ME | O | EVP | M.d | 0 | 0.00 | 0 | 1 | 87 | 2 | D | | | | | | | | | | | | | | |
2/17/26 19:31 | 2/14/26 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Schreck Michael | ME | O | EVP | M.d | 0 | 0.00 | 0 | 2 | 173 | 3 | D | | | | | | | | | | | | | | |
2/17/26 19:30 | 2/14/26 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Mazelsky Jonathan Jay | ME | DO | P,CEO | M.d | 0 | 0.00 | 0 | 2 | 3 | 84 | D | | | | | | | | | | | | | | |
2/17/26 19:30 | 2/14/26 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Lane Michael | ME | O | EVP | M.d | 0 | 0.00 | 0 | 1 | 15 | 9 | D | | | | | | | | | | | | | | |
2/17/26 19:30 | 2/14/26 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Johnson Michael Perkins | ME | O | EVP | M.d | 0 | 0.00 | 0 | 1 | 26 | 3 | D | | | | | | | | | | | | | | |
2/17/26 19:30 | 2/14/26 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Hunt Nimrata | ME | O | EVP | M.d | 0 | 0.00 | 0 | 3 | 13 | 23 | D | | | | | | | | | | | | | | |
2/17/26 19:30 | 2/14/26 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Fennell George | ME | O | EVP | M.d | 0 | 0.00 | 0 | 0 | 5 | 10 | D | | | | | | | | | | | | | | |
2/17/26 19:30 | 2/14/26 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Erickson Michael G | ME | O | EVP | M.d | 0 | 0.00 | 0 | 2 | 23 | 13 | D | | | | | | | | | | | | | | |
2/17/26 19:30 | 2/14/26 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Emerson Andrew | ME | O | EVP,CFO, | M.d | 0 | 0.00 | 0 | 0 | 12 | 4 | D | | | | | | | | | | | | | | |
2/11/26 17:01 | 2/9/26 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Fennell George | ME | O | EVP | M.dm | 870 | 67.85 | 0 | 13 | | 10 | D | | | | | | | | | | | | | | |
2/11/26 17:01 | 2/10/26 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Fennell George | ME | O | EVP | S.d | -7,337 | 646.72 | 0 | -11 | -54 | 10 | D | | | | | | | | | | | | | | |
11/10/25 17:01 | 11/7/25 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Hunt Nimrata | ME | O | EVP | M.d | 4,790 | 382.28 | 0 | 13 | 143 | 21 | D | | | | | | | | | | | | | | |
11/10/25 17:01 | 11/7/25 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Hunt Nimrata | ME | O | EVP | S.d | -6,629 | 703.34 | 0 | -9 | -31 | 21 | D | | | | | | | | | | | | | | |
9/3/25 17:56 | 9/1/25 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Smith Martin Alexander | ME | O | EVP | M.d | 0 | 0.00 | 0 | 0 | 1 | 1 | D | | | | | | | | | | | | | | |
8/26/25 17:00 | 8/22/25 | IDXX | BizSv | Paper | Manifold Business Forms | Szostak M Anne | ME | D | | M.d | 452 | 206.62 | 0 | 2 | | 2 | M | | | | | | | | | | | | | | |
8/26/25 17:00 | 8/22/25 | IDXX | BizSv | Paper | Manifold Business Forms | Szostak M Anne | ME | D | | S.d | -1,416 | 647.33 | 0 | -2 | -51 | 2 | M | | | | | | | | | | | | | | |
8/14/25 18:01 | 8/12/25 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Erickson Michael G | ME | O | EVP | S | -264 | 649.96 | 0 | 0 | -3 | 11 | D | | | | | | | | | | | | | | |
8/13/25 17:17 | 8/11/25 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Hunt Nimrata | ME | O | EVP | S.d | -788 | 656.53 | 0 | -1 | -6 | 18 | D | | | | | | | | | | | | | | |
8/13/25 17:17 | 8/12/25 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Hunt Nimrata | ME | O | EVP | M.d | 299 | 244.16 | 0 | 1 | 7 | 18 | D | | | | | | | | | | | | | | |
8/12/25 17:00 | 8/8/25 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Underberg Sharon E. | ME | O | EVP,GC,C | M.dm | 1,227 | 217.89 | 0 | 6 | 798 | 6 | D | | | | | | | | | | | | | | |
8/12/25 17:00 | 8/8/25 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Underberg Sharon E. | ME | O | EVP,GC,C | S.d | -3,551 | 651.60 | 0 | -5 | -46 | 6 | D | | | | | | | | | | | | | | |
8/12/25 17:00 | 8/8/25 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Mazelsky Jonathan Jay | ME | DO | P,CEO | M.d | 110 | 598.49 | 0 | 0 | 0 | 83 | D | | | | | | | | | | | | | | |
8/11/25 18:00 | 8/7/25 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Emerson Andrew | ME | O | EVP,CFO, | M.d | 262 | 141.60 | 0 | 2 | 91 | 4 | D | | | | | | | | | | | | | | |
8/8/25 21:00 | 8/6/25 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Hunt Nimrata | ME | O | EVP | M.d | 2,400 | 187.57 | 0 | 13 | 238 | 18 | D | | | | | | | | | | | | | | |
8/8/25 21:00 | 8/6/25 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Hunt Nimrata | ME | O | EVP | S.d | -4,503 | 630.43 | 0 | -7 | -28 | 18 | D | | | | | | | | | | | | | | |
8/8/25 20:38 | 8/6/25 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Mazelsky Jonathan Jay | ME | DO | P,CEO | M.d | 1,985 | 67.85 | 0 | 29 | 54 | 83 | D | | | | | | | | | | | | | | |
8/8/25 20:38 | 8/6/25 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Mazelsky Jonathan Jay | ME | DO | P,CEO | S.d | -18,492 | 631.98 | 0 | -29 | -26 | 83 | D | | | | | | | | | | | | | | |
8/8/25 20:37 | 8/6/25 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Lane Michael | ME | O | EVP | M.d | 2,324 | 276.27 | 0 | 8 | | 8 | D | | | | | | | | | | | | | | |
8/8/25 20:37 | 8/6/25 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Lane Michael | ME | O | EVP | S.d | -5,280 | 627.74 | 0 | -8 | -52 | 8 | D | | | | | | | | | | | | | | |
6/3/25 17:00 | 6/1/25 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Johnson Michael Perkins | ME | O | EVP | M.d | 0 | 0.00 | 0 | 3 | | 2 | D | | | | | | | | | | | | | | |
5/23/25 17:00 | 5/21/25 | IDXX | BizSv | Paper | Manifold Business Forms | Szostak M Anne | ME | D | | M.d | 168 | 160.28 | 0 | 1 | 103 | 2 | M | | | | | | | | | | | | | | |
5/23/25 17:00 | 5/21/25 | IDXX | BizSv | Paper | Manifold Business Forms | Szostak M Anne | ME | D | | S.d | -1,183 | 512.97 | 0 | -2 | -53 | 2 | M | | | | | | | | | | | | | | |
5/14/25 17:00 | 5/13/25 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Junius Daniel M | ME | D | | M.d | 708 | 263.81 | 0 | 3 | 432 | 3 | D | | | | | | | | | | | | | | |
5/14/25 17:00 | 5/13/25 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Junius Daniel M | ME | D | | S.d | -1,359 | 506.41 | 0 | -3 | -45 | 3 | D | | | | | | | | | | | | | | |
5/13/25 17:00 | 5/9/25 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Vandebroek Sophie V. | ME | D | | M.d | 363 | 283.59 | 0 | 1 | 16 | 9 | D | | | | | | | | | | | | | | |
5/13/25 17:00 | 5/9/25 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Vandebroek Sophie V. | ME | D | | S.d | -628 | 491.34 | 0 | -1 | -12 | 9 | D | | | | | | | | | | | | | | |
5/8/25 19:01 | 5/6/25 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Vandebroek Sophie V. | ME | D | | M.d | 0 | 0.00 | 0 | 0 | 3 | 9 | D | | | | | | | | | | | | | | |
5/8/25 19:01 | 5/6/25 | IDXX | BizSv | Paper | Manifold Business Forms | Szostak M Anne | ME | D | | M.d | 0 | 0.00 | 0 | 0 | 9 | 3 | D | | | | | | | | | | | | | | |
5/8/25 19:01 | 5/6/25 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Kingsley Lawrence D | ME | D | | M.d | 0 | 0.00 | 0 | 0 | 4 | 9 | D | | | | | | | | | | | | | | |
5/8/25 19:01 | 5/6/25 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Junius Daniel M | ME | D | | M.d | 0 | 0.00 | 0 | 0 | 9 | 3 | D | | | | | | | | | | | | | | |
5/8/25 19:00 | 5/6/25 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Essig Stuart | ME | D | | M.d | 0 | 0.00 | 0 | 0 | 13 | 2 | D | | | | | | | | | | | | | | |
2/18/25 21:44 | 2/14/25 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | McKeon Brian P | ME | O | EVP,CFO, | M.d | 0 | 0.00 | 0 | 1 | 2 | 50 | D | | | | | | | | | | | | | | |
2/18/25 21:43 | 2/14/25 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Smith Martin Alexander | ME | O | EVP | M.d | 0 | 0.00 | 0 | 1 | 765 | 1 | D | | | | | | | | | | | | | | |
2/18/25 21:43 | 2/14/25 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Schreck Michael | ME | O | EVP | M.d | 0 | 0.00 | 0 | 1 | 294 | 2 | D | | | | | | | | | | | | | | |
2/18/25 21:43 | 2/14/25 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Mazelsky Jonathan Jay | ME | DO | P,CEO | M.d | 0 | 0.00 | 0 | 3 | 3 | 83 | D | | | | | | | | | | | | | | |
2/18/25 21:43 | 2/14/25 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Lane Michael | ME | O | EVP | M.d | 0 | 0.00 | 0 | 1 | 13 | 8 | D | | | | | | | | | | | | | | |
2/18/25 21:43 | 2/14/25 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Johnson Michael Perkins | ME | O | EVP | M.d | 0 | 0.00 | 0 | 0 | 316 | 0 | D | | | | | | | | | | | | | | |
2/18/25 21:43 | 2/14/25 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Hunt Nimrata | ME | O | EVP | M.d | 0 | 0.00 | 0 | 1 | 8 | 12 | D | | | | | | | | | | | | | | |
2/18/25 21:42 | 2/14/25 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Fennell George | ME | O | EVP | M.d | 0 | 0.00 | 0 | 0 | 4 | 8 | D | | | | | | | | | | | | | | |
2/18/25 21:42 | 2/14/25 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Erickson Michael G | ME | O | EVP | M.d | 0 | 0.00 | 0 | 1 | 3 | 21 | D | | | | | | | | | | | | | | |
2/12/25 17:04 | 2/11/25 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Erickson Michael G | ME | O | EVP | M.d | 105 | 67.85 | 0 | 2 | 8 | 21 | D | | | | | | | | | | | | | | |
2/11/25 17:00 | 2/7/25 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Fennell George | ME | O | EVP | M.dm | 894 | 79.54 | 0 | 11 | | 8 | D | | | | | | | | | | | | | | |
2/11/25 17:00 | 2/10/25 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Fennell George | ME | O | EVP | S.d | -4,619 | 462.53 | 0 | -10 | -55 | 8 | D | | | | | | | | | | | | | | |
2/10/25 17:03 | 2/7/25 | IDXX | BizSv | Paper | Manifold Business Forms | Szostak M Anne | ME | D | | S | -1,398 | 465.95 | 0 | -3 | -49 | 3 | I | | | | | | | | | | | | | | |
11/29/24 17:00 | 11/27/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Vandebroek Sophie V. | ME | D | | S | -145 | 420.44 | 0 | 0 | -28 | 1 | D | | | | | | | | | | | | | | |
9/9/24 16:18 | 9/6/24 | IDXX | BizSv | Paper | Manifold Business Forms | Szostak M Anne | ME | D | | S | -235 | 469.37 | 0 | -1 | -8 | 6 | I | | | | | | | | | | | | | | |
9/4/24 20:20 | 9/1/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Schreck Michael | ME | O | EVP | M.d | 0 | 0.00 | 0 | 0 | 22 | 1 | D | | | | | | | | | | | | | | |
9/4/24 20:03 | 9/1/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Smith Martin Alexander | ME | O | EVP | M.d | 0 | 0.00 | 0 | 0 | 4 | 1 | D | | | | | | | | | | | | | | |
8/7/24 17:01 | 8/5/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | McKeon Brian P | ME | O | EVP,CFO, | M.d | 0 | 0.00 | 0 | 0 | 0 | 49 | D | | | | | | | | | | | | | | |
8/7/24 17:00 | 8/5/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Mazelsky Jonathan Jay | ME | DO | P,CEO | M.d | 0 | 0.00 | 0 | 0 | 0 | 82 | D | | | | | | | | | | | | | | |
5/20/24 17:00 | 5/17/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Claflin Bruce L. | ME | D | | S | -108 | 540.80 | 0 | 0 | -10 | 2 | D | | | | | | | | | | | | | | |
5/8/24 19:02 | 5/6/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Vandebroek Sophie V. | ME | D | | M.d | 0 | 0.00 | 0 | 0 | 3 | 10 | D | | | | | | | | | | | | | | |
5/8/24 19:02 | 5/6/24 | IDXX | BizSv | Paper | Manifold Business Forms | Szostak M Anne | ME | D | | M.d | 0 | 0.00 | 0 | 0 | 4 | 7 | M | | | | | | | | | | | | | | |
5/8/24 19:02 | 5/6/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Kingsley Lawrence D | ME | D | | M.d | 0 | 0.00 | 0 | 0 | 4 | 9 | D | | | | | | | | | | | | | | |
5/8/24 19:01 | 5/6/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Essig Stuart | ME | D | | M.d | 0 | 0.00 | 0 | 0 | 15 | 2 | D | | | | | | | | | | | | | | |
5/8/24 19:01 | 5/6/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Collins Asha | ME | D | | M.d | 0 | 0.00 | 0 | 0 | 49 | 1 | D | | | | | | | | | | | | | | |
5/8/24 19:00 | 5/6/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Britt Irene Chang | ME | D | | M.d | 0 | 0.00 | 0 | 0 | New | 0 | D | | | | | | | | | | | | | | |
5/8/24 19:00 | 5/6/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | M.d | 0 | 0.00 | 0 | 0 | 0 | 578 | D | | | | | | | | | | | | | | |
3/7/24 17:00 | 3/6/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Polewaczyk James F | ME | O | EVP | M.d | 3,424 | 422.45 | 0 | 8 | 311 | 11 | D | | | | | | | | | | | | | | |
3/7/24 17:00 | 3/6/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Polewaczyk James F | ME | O | EVP | S.d | -4,526 | 558.44 | 0 | -8 | -43 | 11 | D | | | | | | | | | | | | | | |
3/7/24 17:00 | 3/5/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Vandebroek Sophie V. | ME | D | | M.d | 345 | 245.79 | 0 | 1 | 18 | 9 | D | | | | | | | | | | | | | | |
3/7/24 17:00 | 3/5/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Vandebroek Sophie V. | ME | D | | S.d | -790 | 562.98 | 0 | -1 | -13 | 9 | D | | | | | | | | | | | | | | |
2/22/24 17:02 | 2/21/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Mazelsky Jonathan Jay | ME | DO | P,CEO | M.d | 100 | 206.94 | 0 | 0 | 1 | 82 | D | | | | | | | | | | | | | | |
2/20/24 17:01 | 2/16/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Underberg Sharon E. | ME | O | EVP,GC,C | M.d | 100 | 206.94 | 0 | 0 | 9 | 6 | D | | | | | | | | | | | | | | |
2/20/24 17:00 | 2/15/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | McKeon Brian P | ME | O | EVP,CFO, | M.d | 100 | 206.94 | 0 | 0 | 1 | 49 | D | | | | | | | | | | | | | | |
2/16/24 17:58 | 2/14/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Smith Martin Alexander | ME | O | EVP | M.d | 0 | 0.00 | 0 | 0 | 244 | 0 | D | | | | | | | | | | | | | | |
2/16/24 17:58 | 2/14/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Schreck Michael | ME | O | EVP | M.d | 0 | 0.00 | 0 | 0 | 88 | 1 | D | | | | | | | | | | | | | | |
2/16/24 17:57 | 2/14/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Polewaczyk James F | ME | O | EVP | M.d | 0 | 0.00 | 0 | 1 | 9 | 11 | D | | | | | | | | | | | | | | |
2/16/24 17:57 | 2/14/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | McKeon Brian P | ME | O | EVP,CFO, | M.d | 0 | 0.00 | 0 | 2 | 4 | 48 | D | | | | | | | | | | | | | | |
2/16/24 17:56 | 2/14/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Mazelsky Jonathan Jay | ME | DO | P,CEO | M.d | 0 | 0.00 | 0 | 4 | 5 | 82 | D | | | | | | | | | | | | | | |
2/16/24 17:56 | 2/14/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Lane Michael | ME | O | EVP | M.d | 0 | 0.00 | 0 | 1 | 15 | 7 | D | | | | | | | | | | | | | | |
2/16/24 17:56 | 2/14/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Johnson Michael Perkins | ME | O | EVP,CHRO | M.d | 0 | 0.00 | 0 | 0 | 999% | 0 | D | | | | | | | | | | | | | | |
2/16/24 17:55 | 2/14/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Hunt Nimrata | ME | O | EVP | M.d | 0 | 0.00 | 0 | 1 | 6 | 12 | D | | | | | | | | | | | | | | |
2/16/24 17:55 | 2/14/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Fennell George | ME | O | SVP,Chie | M.d | 0 | 0.00 | 0 | 0 | 6 | 7 | D | | | | | | | | | | | | | | |
2/16/24 17:54 | 2/14/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Erickson Michael G | ME | O | EVP | M.d | 0 | 0.00 | 0 | 0 | 5 | 11 | D | | | | | | | | | | | | | | |
2/9/24 17:03 | 2/8/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Fennell George | ME | O | SVP,Chie | M.d | 608 | 62.00 | 0 | 10 | | 7 | D | | | | | | | | | | | | | | |
2/9/24 17:03 | 2/8/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Fennell George | ME | O | SVP,Chie | S.d | -4,705 | 573.87 | 0 | -8 | -55 | 7 | D | | | | | | | | | | | | | | |
2/9/24 17:01 | 2/7/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | McKeon Brian P | ME | O | EVP,CFO, | M.d | 3,303 | 141.60 | 0 | 23 | 95 | 48 | D | | | | | | | | | | | | | | |
2/9/24 17:01 | 2/7/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | McKeon Brian P | ME | O | EVP,CFO, | S.d | -13,296 | 570.01 | 0 | -23 | -33 | 48 | D | | | | | | | | | | | | | | |
2/9/24 17:00 | 2/7/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Mazelsky Jonathan Jay | ME | DO | P,CEO | M.d | 814 | 67.85 | 0 | 12 | 18 | 79 | D | | | | | | | | | | | | | | |
2/9/24 17:00 | 2/7/24 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Mazelsky Jonathan Jay | ME | DO | P,CEO | S.d | -6,871 | 572.61 | 0 | -12 | -13 | 79 | D | | | | | | | | | | | | | | |
12/8/23 17:00 | 12/7/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Polewaczyk James F | ME | O | EVP | M.d | 2,955 | 253.92 | 0 | 12 | | 10 | D | | | | | | | | | | | | | | |
12/8/23 17:00 | 12/7/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Polewaczyk James F | ME | O | EVP | S.d | -6,072 | 521.79 | 0 | -12 | -54 | 10 | D | | | | | | | | | | | | | | |
12/6/23 17:01 | 12/4/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Mazelsky Jonathan Jay | ME | DO | P,CEO | M.d | 1,068 | 79.54 | 0 | 13 | 20 | 79 | D | | | | | | | | | | | | | | |
12/6/23 17:01 | 12/4/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Mazelsky Jonathan Jay | ME | DO | P,CEO | S.d | -3,657 | 513.05 | 0 | -7 | -8 | 79 | D | | | | | | | | | | | | | | |
11/8/23 17:09 | 11/7/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Lane Michael | ME | O | EVP | M.d | 231 | 133.76 | 0 | 2 | 37 | 6 | D | | | | | | | | | | | | | | |
9/6/23 17:01 | 9/1/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Smith Martin Alexander | ME | O | EVP | M.d | 0 | 0.00 | 0 | 0 | 9 | 0 | D | | | | | | | | | | | | | | |
9/5/23 17:01 | 8/31/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Mazelsky Jonathan Jay | ME | DO | P,CEO | M.d | 1,068 | 79.54 | 0 | 13 | 23 | 73 | D | | | | | | | | | | | | | | |
9/5/23 17:01 | 8/31/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Mazelsky Jonathan Jay | ME | DO | P,CEO | S.d | -6,873 | 512.01 | 0 | -13 | -16 | 73 | D | | | | | | | | | | | | | | |
8/31/23 17:17 | 8/29/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Polewaczyk James F | ME | O | EVP | M.d | 2,438 | 144.21 | 0 | 17 | | 10 | D | | | | | | | | | | | | | | |
8/31/23 17:17 | 8/29/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Polewaczyk James F | ME | O | EVP | S.d | -11,696 | 510.56 | 0 | -23 | -70 | 10 | D | | | | | | | | | | | | | | |
8/17/23 19:37 | 8/15/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Ayers Jonathan W | ME | D | | S | 0 | 0.00 | 0 | 0 | 0 | 596 | D | | | | | | | | | | | | | | |
8/8/23 17:59 | 8/5/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | McKeon Brian P | ME | O | EVP,CFO, | M.d | 0 | 0.00 | 0 | 0 | 0 | 48 | D | | | | | | | | | | | | | | |
8/8/23 17:59 | 8/5/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Mazelsky Jonathan Jay | ME | DO | P,CEO | M.d | 0 | 0.00 | 0 | 0 | 1 | 73 | D | | | | | | | | | | | | | | |
8/7/23 17:04 | 8/3/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Lane Michael | ME | O | EVP | M.d | 3,005 | 187.47 | 0 | 16 | | 5 | D | | | | | | | | | | | | | | |
8/7/23 17:04 | 8/3/23 | IDXX | Health | Diagn | In Vitro & In Vivo Diagnostic | Lane Michael | ME | O | EVP | S.d | -8,174 | 510.00 | 0 | -16 | -78 | 5 | D | | | | | | | | | | | | | | |